Xperii is a web platform that connects researchers with individuals who are interested in participating in paid studies and clinical trials. Xperii makes it easy to find the studies one is interested in by automatically filtering for only the ones you qualify for, and enabling the ability to filter by different features of the study.
The website or mobile app integrates the entire process of applying to the study, communicating with the researcher, scheduling a time to visit, and even getting paid. Participants are able to make money flexibly, on their own schedule, and researchers can make meaningful discoveries that advance science, medicine, and even make your favorite products even better.
The Inception Story
There was a clear disconnect in the ability for individuals to learn about and sign up for research studies of all sorts, and for researchers to reach out to these study participants. Additionally studies showed that many members of the general public were unfamiliar with clinical trials, and were unaware of opportunities for healthy individuals to participate in trials. Another study found that 85% of cancer patients were unaware of clinical trial opportunities, but that 75% of them would have participated in a trial if they’d known of its existence. As a result clinical trials were delayed, costing the US clinical trial industry an estimated $8.6 billion annually and delaying the launch of life-saving medical treatments.
Cynthia and Evan collaborated on scientific research for over 5 years, and it was during this time that Cynthia had the idea for Xperii in order to solve the problems they were facing recruiting subjects for their own research.
Xperii connects these two parties in a simple platform that can be accessed through the website or incoming mobile applications. Having everyone in one place, Xperii goes one step beyond by making the connection and helping subjects apply to studies, communicate their questions to the researchers, send sensitive medical information securely. This makes research studies convenient for the researcher and the participants, and it eliminates the tightest bottlenecks in running a behavioral or clinical study.
The Story so Far
Xperii is backed by Founder.org, with a permanent mentor-based partnership.The company has also received a $50,000 investment from Sylvia and Roger Cox – Roger is a VP of Research at Gartner with world-renowned expertise in the data-storage industry and professional excellence in analyzing market trends. They are now closing a $20,000 investment and partnership with a health tech accelerator.
Xperii has fully automated process that is markedly different from traditional strategies. Users can find all sorts of research studies, from focus groups to academic research to clinical trials to product testing. Most importantly, Xperii don’t just list research studies, it also helps users apply, communicate, schedule the study, complete follow-up surveys, and get paid, all through our platform.
For researchers, the company offers a fully automated research recruitment and management system that also facilitates collecting and analyzing data for the duration of their study, no matter how long it may be.
Xperii charges the Researchers based on custom screening methods, for which a fee is charged for each user that completes the screening. For Customers, a small cut of that payment is taken from the researcher if a customer chooses to pay their study participants through this platform.
In the coming years the company plans to offer a complete study recruitment and management SaaS platform to researchers and study participants in America’s largest cities, and will be preparing to expand our offering internationally.
As we grow, we’re looking to expand this to help researchers handle every aspect of their studies, from recruitment, to data collection, to analysis, follow-up and more. We see Xperii as a centralized platform that will make research more efficient and more effective, making science get done better and faster, comments the company founders
Xperii also plans to be partnering with the best organizations that are working to support individuals with rare conditions, and donating a significant portion of our profits directly back to them to fund patient treatment, outreach, and medical advancement.
Latest posts by Akash Boaz (see all)
- HR Tech & Analytics Platform, Darwinbox, Raises Capital from Multiple Funds Including Mohandas Pai’s 3one4 - July 27, 2016
- Hyderabad based NewsDistill announces the first personalized news player in the world - July 21, 2016
- Bangalore based Home rental startup Zenify raises $1mn in funding - May 11, 2016